Bronze
1drop Inc. is a fastgrowing healthcare company that provides innovative solutions for the prevention, improvement, and monitoring of disease. We will lead the innovations and changes among the global healthcare industry in the field of mobile healthcare, a digital platform where you can measure various components of the blood with a single device and biosensor, and in the field of molecular diagnostics, a form of accurate and stable molecular detection of biomarkers with 1drop's special technology. Through the pandemic of infectious diseases such as COVID-19, we could find out overall healthcare system has so many unmet clinical demands of existing disease response not only for COVID-19 pandemic but also for original disease. 1drop has recently been growing by providing healthcare solutions against COVID-19 pandemic/endemic with innovative technologies and products. Going forward, we will do our best to provide a chance for mankind to live healthier by developing innovative digital/mobile technologies and supplying highly reliable products that can satisfy the unmet demand of the existing healthcare system.
The 1copy™ BCR-ABL qPCR Kit is specifically designed for the assessment, treatment, and monitoring of Chronic Myelogenous Leukemia (CML), a type of leukemia caused by certain gene expressions. This kit contains reagents intended for in vitro diagnostics. By utilizing real-time Polymerase Chain Reaction (PCR), it quantitatively measures the presence of BCR-ABL1 fusion mRNA in total RNA extracted from a patient's whole blood who has been diagnosed with chronic myeloid leukemia. One of the remarkable features of the 1copy™ BCR-ABL qPCR Kit is its capability to identify multiple target mRNAs simultaneously, streamlining the process and enhancing convenience. This one-step approach significantly accelerates the testing procedure. The sensitivity of the 1copy™ BCR-ABL qPCR Kit is notable, as it can detect even extremely low levels of BCR-ABL1 fusion mRNA. It boasts a Complete Molecular Response (CMR) of more than 0.0032% International Scale (IS), indicating its ability to pick up even minute quantities of the gene expression. Furthermore, the versatility of the kit is apparent in its ability to detect various genotypes associated with CML in a single test. It can detect Major type (p210 : e14a2, e13a2), Minor type (p190 : e1a2), Micro type (p230 : e19a2) of patient's genotype in a single test. Overall, the 1copy™ BCR-ABL qPCR Kit provides a comprehensive solution for individuals at every level of the healthcare journey – patients, healthcare providers, and distributors alike. This advanced kit plays a crucial role in the evaluation, management, and ongoing monitoring of Chronic Myelogenous Leukemia, contributing to more effective treatment and patient care.